Abstract |
Cancer stem cells (CSCs) are involved in metastatic colorectal cancer recurrence, but no effective therapy targeting these cells is currently available. Because trifluridine (FTD)/ tipiracil therapy is used for refractory colorectal cancer, we sought to determine whether FTD is effective against CSC-like cells. CD44+CD133+ high-expressing and other populations of human DLD-1 colon cancer cells were separately isolated through fluorescence-activated cell sorting. The sphere-forming activity of each population and the anti-sphere-forming effects of FTD and fluorouracil (5-FU) on CD44+CD133+ cells were then measured. CD44+CD133+ DLD-1 cells formed substantially more spheres than other cells. Moreover, treating CD44+CD133+ DLD-1 cells with subtoxic concentrations of FTD (1 µM) inhibited sphere formation, and this was superior to the effect of subtoxic concentrations (1 µM) of 5-FU. The associated inhibition rates for FTD and 5-FU were 58.2% and 26.1%, respectively. Further, CD44+CD133+ DLD-1 cells expressed higher levels of thymidine kinase 1, which is responsible for FTD phosphorylation, than DLD-1 cells, and FTD was incorporated into the DNA of CD44+CD133+ DLD-1 cells. Thus, our data show that FTD treatment is effective against CSC-like cells and might be applied as CSC-targeting chemotherapy for tumor subtypes with high CD44 and CD133 expression.
|
Authors | Kenta Tsunekuni, Masamitsu Konno, Naotsugu Haraguchi, Jun Koseki, Ayumu Asai, Kazuaki Matsuoka, Takashi Kobunai, Teiji Takechi, Yuichiro Doki, Masaki Mori, Hideshi Ishii |
Journal | Scientific reports
(Sci Rep)
Vol. 9
Issue 1
Pg. 14861
(10 16 2019)
ISSN: 2045-2322 [Electronic] England |
PMID | 31619711
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- AC133 Antigen
- Antimetabolites, Antineoplastic
- CD44 protein, human
- Drug Combinations
- Hyaluronan Receptors
- PROM1 protein, human
- Pyrrolidines
- Thymidine Kinase
- thymidine kinase 1
- tipiracil
- Thymine
- Trifluridine
- Fluorouracil
|
Topics |
- AC133 Antigen
(genetics, metabolism)
- Antimetabolites, Antineoplastic
(pharmacology)
- Cell Line, Tumor
- Colon
(metabolism, pathology)
- Drug Combinations
- Drug Synergism
- Fluorouracil
(pharmacology)
- Gene Expression
- Humans
- Hyaluronan Receptors
(genetics, metabolism)
- Inhibitory Concentration 50
- Neoplastic Stem Cells
(drug effects, metabolism, pathology)
- Pyrrolidines
(pharmacology)
- Spheroids, Cellular
(drug effects, metabolism, pathology)
- Thymidine Kinase
(genetics, metabolism)
- Thymine
(pharmacology)
- Trifluridine
(pharmacology)
|